Hemostemix Announces Settlement Agreement
Calgary, Alberta--(Newsfile Corp. - March 23, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is...
Day: March 23, 2022
Sonendo Inc. Reports Fourth Quarter 2021 Financial Results and Issues Full Year 2022 Revenue Guidance
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (“Sonendo”), a leading dental technology company and developer of the GentleWave® System, today reported financial...
EastWest to Compensate Management for Personal Guarantees of Company Debt
PENTICTON, BC / ACCESSWIRE / March 23, 2022 / EastWest Bioscience Inc. ("EastWest" or "Company") (TSXV:EAST), reports that, pursuant to...
Celcuity Inc. Reports Fourth Quarter and Full Year 2021 Financial Results, Pivotal Phase 3 Trial Design for Gedatolisib in the Treatment of Advanced Breast Cancer, and Business Updates
Finalized pivotal Phase 3 trial design following formal meetings with FDAReceived FDA Fast Track designation for gedatolisib in HR+/HER2- metastatic...
XVIVO Obtains Its First Certificate Under EU Medical Device Regulation (MDR) for Kidney Assist Transport
GOTHENBURG, SE / ACCESSWIRE / March 23, 2022 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV)Today XVIVO announces an important milestone as the...
ModMed® Launches AMP Marketing Services to Help Practices Attract New Patients, Manage Reputation and Improve Engagement
Healthcare technology leader to unveil ModMed AMP, a solution that includes website design & management, digital marketing, reputation management and...
Lobe Sciences Ltd. to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and Hosted by M-Vest on March 28th – 30th from 9:00 A.M. – 5:00 P.M. EDT
Vancouver, British Columbia--(Newsfile Corp. - March 23, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company")...
First Trust Launches First Trust Nasdaq Lux Digital Health Solutions ETF
An index-tracking ETF that provides exposure to companies that comprise the digital health industry WHEATON, Ill.--(BUSINESS WIRE)--First Trust Advisors L.P....
9am.health Further Expands Virtual Diabetes Clinic by Partnering With Ascensia to Add the CONTOUR®NEXT ONE Blood Glucose Meter to Its Patient Toolkit
Blood glucose meters allow regular at-home blood sugar checks to complement telemedicine visits, diabetes medications, lab tests, and ongoing diabetes...
SullivanCotter Enhances Provider Performance Management Technology™ User Experience for Physicians and Advanced Practice Providers
CHICAGO , March 23, 2022 /PRNewswire/ -- SullivanCotter, the nation's leading independent consulting firm in the assessment and development of total...
NeonMind Unveils Initial Treatment Offering at Specialty Mental Health Clinic in Mississauga
To Deliver Low Dose Intravenous Ketamine for Mood and Anxiety Disorders, a Recommended Treatment by Canadian Guidelines, Upon Clinic LicensingOAKVILLE,...
Mercury Medical Donates Medical Devices to Ukrainian Medical Association of North America, UMANA Foundation, to Help Save Lives
CLEARWATER, FL / ACCESSWIRE / March 23, 2022 / Mercury Medical responds to the plea from the Ukrainian Medical Association...
Cosmos Holdings CEO Provides Letter to Shareholders
CHICAGO, IL / ACCESSWIRE / March 23, 2022 / Cosmos Holdings, Inc. ("the Company") (Nasdaq:COSM), an international pharmaceutical company with...
Aytu BioPharma Announces FDA Orange Book Listing of Newly Issued Patent for Cotempla XR-ODT(R)
ENGLEWOOD, CO / ACCESSWIRE / March 23, 2022 / Aytu BioPharma, Inc. (NASDAQ:AYTU), a pharmaceutical company focused on developing and...
BullFrog AI Enters into Licensing Agreement with Johns Hopkins University for Use of Novel Formulation of Mebendazole for Treatment of Cancer
GAITHERSBURG, MD / ACCESSWIRE / March 23, 2022 / BullFrog AI Holdings, Inc., a biopharmaceutical company focused on applying its...
NeonMind Announces Positive Preclinical Results Demonstrating the Efficacy of Psilocybin in Reducing Weight Gain in Obese Animal Subjects
Data Further Validates Psilocybin as a Drug Candidate for Obesity and Supports Development of NeonMind's Drug Programs NEO-001 and NEO-002OAKVILLE,...
Moderna Announces its COVID-19 Vaccine Phase 2/3 Study in Children 6 Months to Under 6 Years Has Successfully Met Its Primary Endpoint
Two 25 μg doses of mRNA-1273 in participants 6 months to under 6 years met primary endpoint with robust neutralizing...
9 Meters Biopharma Provides Business Update and Reports Financial Results for Fourth Quarter and Full Year 2021
RALEIGH, NC / ACCESSWIRE / March 23, 2022 / 9 Meters Biopharma, Inc. (NASDAQ:NMTR), a clinical-stage company pioneering novel treatments...
South Rampart Pharma Announces Patient Enrollment and Dosing Underway in Phase 1 Study Evaluating Novel Non-Opioid Approach to Pain with Lead Program, SRP-3D (DA)
SRP-3D (DA) has demonstrated a compelling safety profile over currently available pain medicationsPotential to address the significant unmet need for...
PacBio Opens European Headquarters in London
PacBio Logo in New London Office PacBio opens new office in London.Company Announces New European Headquarters to Serve Growing Customer...